Funding

Dr. Quinones-Hinojosa's lab at Mayo Clinic leads and contributes to brain tumor stem cell research that's funded by the National Institutes of Health (NIH), the National Cancer Institute (NCI) and other sources.

Grants

Investigator & Role Grant Title Funding Source Duration

Alfredo Quinones-Hinojosa, M.D., principal investigator; Xingde Li, Ph.D., contact principal investigator

  • Intra-Operative Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging
  • (R01CA200399)

NCI

03/01/16-02/28/21

Alfredo Quinones-Hinojosa, M.D., principal investigator; Jordan Green, Ph.D., contact principal investigator

  • Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer
  • (R01 CA195503)

NCI

01/01/16-12/31/20

Alfredo Quinones-Hinojosa, M.D., site principal investigator; Shuli Xia, Ph.D., principal investigator

  • Methyl-CpG-dependent transcription factor function in human glioma
  • (R01 NS091165-01)

NIH

12/01/15-11/30/20

Alfredo Quinones-Hinojosa, M.D., principal investigator; Rachel Sarabia Estrada, D.V.M., Ph.D., co-investigator

  • Targeting Spine Metastatic Tumors Using Engineered Mesenchymal Stem Cells. Research Supplement to Promote Diversity in Health-Related Research
  • (R01 CA18382702S1)

NCI

08/05/15-04/30/20

Alfredo Quinones-Hinojosa, M.D., principal investigator

  • BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
  • (R01 CA183827)

NCI

05/08/15-04/30/20

Alfredo Quinones-Hinojosa, M.D., site principal investigator; Jinyuan Zhou, Ph.D.; Peter C.M. van Zijl, Ph.D., principal investigator

  • Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
  • (R01CA166171)

NIH

02/05/13-01/31/18

Alfredo Quinones-Hinojosa, M.D., site principal investigator; Jordan Green, Ph.D., contact principal investigator

  • Gene Delivery of Nanoparticles to Treat Glioblastoma Multiforme
  • (R01 EB016721)

NIH

01/01/13-12/31/17

Alfredo Quinones-Hinojosa, M.D., site principal investigator; Rajini Rao, Ph.D., co-principal investigator

Targeting a Novel Mechanism of Chemoradiation Resistance in Glioblastoma

Allegheny Health Network-Johns Hopkins Fund

05/31/15-04/30/17